Literature DB >> 23255801

Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters.

Shumpei Watanabe1, Yuta Shirogane, Satoshi O Suzuki, Satoshi Ikegame, Ritsuko Koga, Yusuke Yanagi.   

Abstract

Subacute sclerosing panencephalitis (SSPE) is a fatal degenerative disease caused by persistent measles virus (MV) infection in the central nervous system (CNS). From the genetic study of MV isolates obtained from SSPE patients, it is thought that defects of the matrix (M) protein play a crucial role in MV pathogenicity in the CNS. In this study, we report several notable mutations in the extracellular domain of the MV fusion (F) protein, including those found in multiple SSPE strains. The F proteins with these mutations induced syncytium formation in cells lacking SLAM and nectin 4 (receptors used by wild-type MV), including human neuronal cell lines, when expressed together with the attachment protein hemagglutinin. Moreover, recombinant viruses with these mutations exhibited neurovirulence in suckling hamsters, unlike the parental wild-type MV, and the mortality correlated with their fusion activity. In contrast, the recombinant MV lacking the M protein did not induce syncytia in cells lacking SLAM and nectin 4, although it formed larger syncytia in cells with either of the receptors. Since human neuronal cells are mainly SLAM and nectin 4 negative, fusion-enhancing mutations in the extracellular domain of the F protein may greatly contribute to MV spread via cell-to-cell fusion in the CNS, regardless of defects of the M protein.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23255801      PMCID: PMC3571373          DOI: 10.1128/JVI.02632-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  N-(3-Cyanophenyl)-2-phenylacetamide, an effective inhibitor of morbillivirus-induced membrane fusion with low cytotoxicity.

Authors:  K Singethan; G Hiltensperger; S Kendl; J Wohlfahrt; P Plattet; U Holzgrabe; J Schneider-Schaulies
Journal:  J Gen Virol       Date:  2010-08-04       Impact factor: 3.891

2.  The SI strain of measles virus derived from a patient with subacute sclerosing panencephalitis possesses typical genome alterations and unique amino acid changes that modulate receptor specificity and reduce membrane fusion activity.

Authors:  Fumio Seki; Kentaro Yamada; Yuichiro Nakatsu; Koji Okamura; Yusuke Yanagi; Tetsuo Nakayama; Katsuhiro Komase; Makoto Takeda
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

Review 3.  Subacute sclerosing panencephalitis: an update.

Authors:  Jose Gutierrez; Richard S Issacson; Barbara S Koppel
Journal:  Dev Med Child Neurol       Date:  2010-06-15       Impact factor: 5.449

4.  Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM.

Authors:  Takao Hashiguchi; Toyoyuki Ose; Marie Kubota; Nobuo Maita; Jun Kamishikiryo; Katsumi Maenaka; Yusuke Yanagi
Journal:  Nat Struct Mol Biol       Date:  2011-01-09       Impact factor: 15.369

5.  The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence.

Authors:  Minoru Ayata; Kaoru Takeuchi; Makoto Takeda; Shinji Ohgimoto; Seiichi Kato; Luna Bhatta Sharma; Miyuu Tanaka; Mitsuru Kuwamura; Hiroshi Ishida; Hisashi Ogura
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

6.  Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.

Authors:  Matteo Porotto; Barry Rockx; Christine C Yokoyama; Aparna Talekar; Ilaria Devito; Laura M Palermo; Jie Liu; Riccardo Cortese; Min Lu; Heinz Feldmann; Antonello Pessi; Anne Moscona
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

Review 7.  Measles virus infection of the CNS: human disease, animal models, and approaches to therapy.

Authors:  Dajana Reuter; Jürgen Schneider-Schaulies
Journal:  Med Microbiol Immunol       Date:  2010-08       Impact factor: 4.148

Review 8.  Structural and mechanistic studies of measles virus illuminate paramyxovirus entry.

Authors:  Richard K Plemper; Melinda A Brindley; Ronald M Iorio
Journal:  PLoS Pathog       Date:  2011-06-02       Impact factor: 6.823

9.  Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus.

Authors:  Ryan S Noyce; Daniel G Bondre; Michael N Ha; Liang-Tzung Lin; Gary Sisson; Ming-Sound Tsao; Christopher D Richardson
Journal:  PLoS Pathog       Date:  2011-08-25       Impact factor: 6.823

10.  Adherens junction protein nectin-4 is the epithelial receptor for measles virus.

Authors:  Michael D Mühlebach; Mathieu Mateo; Patrick L Sinn; Steffen Prüfer; Katharina M Uhlig; Vincent H J Leonard; Chanakha K Navaratnarajah; Marie Frenzke; Xiao X Wong; Bevan Sawatsky; Shyam Ramachandran; Paul B McCray; Klaus Cichutek; Veronika von Messling; Marc Lopez; Roberto Cattaneo
Journal:  Nature       Date:  2011-11-02       Impact factor: 49.962

View more
  30 in total

1.  Weak cis and trans Interactions of the Hemagglutinin with Receptors Trigger Fusion Proteins of Neuropathogenic Measles Virus Isolates.

Authors:  Yuta Shirogane; Takao Hashiguchi; Yusuke Yanagi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

2.  Efficient reovirus- and measles virus-mediated pore expansion during syncytium formation is dependent on annexin A1 and intracellular calcium.

Authors:  Marta Ciechonska; Tim Key; Roy Duncan
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

3.  SLAM- and nectin-4-independent noncytolytic spread of canine distemper virus in astrocytes.

Authors:  Lisa Alves; Mojtaba Khosravi; Mislay Avila; Nadine Ader-Ebert; Fanny Bringolf; Andreas Zurbriggen; Marc Vandevelde; Philippe Plattet
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

4.  Cell-to-Cell Measles Virus Spread between Human Neurons Is Dependent on Hemagglutinin and Hyperfusogenic Fusion Protein.

Authors:  Yuma Sato; Shumpei Watanabe; Yoshinari Fukuda; Takao Hashiguchi; Yusuke Yanagi; Shinji Ohno
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 5.  Measles virus persistence and its consequences.

Authors:  Diane E Griffin
Journal:  Curr Opin Virol       Date:  2020-05-05       Impact factor: 7.090

6.  Structures of the prefusion form of measles virus fusion protein in complex with inhibitors.

Authors:  Takao Hashiguchi; Yoshinari Fukuda; Rei Matsuoka; Daisuke Kuroda; Marie Kubota; Yuta Shirogane; Shumpei Watanabe; Kouhei Tsumoto; Daisuke Kohda; Richard Karl Plemper; Yusuke Yanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-20       Impact factor: 11.205

7.  Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology.

Authors:  Shumpei Watanabe; Shinji Ohno; Yuta Shirogane; Satoshi O Suzuki; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

8.  Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.

Authors:  Fabrizio Angius; Heidi Smuts; Ksenia Rybkina; Debora Stelitano; Brian Eley; Jo Wilmshurst; Marion Ferren; Alexandre Lalande; Cyrille Mathieu; Anne Moscona; Branka Horvat; Takao Hashiguchi; Matteo Porotto; Diana Hardie
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

9.  Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.

Authors:  Jeremy C Welsch; Aparna Talekar; Cyrille Mathieu; Antonello Pessi; Anne Moscona; Branka Horvat; Matteo Porotto
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Molecular determinants defining the triggering range of prefusion F complexes of canine distemper virus.

Authors:  Mislay Avila; Lisa Alves; Mojtaba Khosravi; Nadine Ader-Ebert; Francesco Origgi; Jürgen Schneider-Schaulies; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  J Virol       Date:  2013-12-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.